InvestorsHub Logo
Followers 19
Posts 334
Boards Moderated 0
Alias Born 07/25/2016

Re: chickpea598 post# 36066

Friday, 10/07/2016 3:01:26 PM

Friday, October 07, 2016 3:01:26 PM

Post# of 48316
The fact that the AA trial is selecting refractory patients rather than just predicted nonresponders based on a biomarker, suggests to me that enrollment will be much quicker than the current combo trial.